Hello Just seeing if my inspired stock sleuthing is correct! Jeff Brown is pitching a cure for childhood blindness, with a 2 year $2000 subscription with a 100% guarantee for CREDIT to another service, money back or nothing as far as I am concerned. So testing with MIT, only company to do human trials and already moving into third stage trials with “CEP290”? as a cure for blindness. Looks very interesting and truly hope it will be successful. The company doing this I think is Editas Medicine and having partnership with Allergen which was recently purchased by Abbvie.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.